UNSPSC 51285806: Opiniazide

This classification denotes an antitubercular agent with the molecular formula C16H15N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KD4681N5W4, chemically known as 5,6-dimethoxyphthalaldehydic acid isonicotinoylhydrazone but more generally known as opiniazide, which bears US NIH Compound Identifier 6871212. European Medicines Agency schedules Opiniazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09449MIG.

The term OPINIAZIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). OPINIAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(C(CCC1OC)/C=N/NC(=O)C1CCNCC1)C(=O)O)C.

UNSPSC 51285806 Opiniazide, a Commodity code, does not reflect the actual procurement activity recently tagged under it. State and local governments are soliciting pharmaceutical products, medical supplies, and pharmacy services — naloxone and drug deactivation systems, medical and first aid supplies for emergency responders, generic pharmaceuticals through cooperative purchasing, and direct-to-manufacturer prescription fulfillment capabilities — none of which align with the opiniazide nomenclature. The issuing bodies include county health departments, municipal fire services, state HHS commissions, and multistate cooperative purchasing alliances. The code shows little relevant recent activity under its stated definition.

Geographic activity spans Florida (Seminole County), Texas (state HHS commission), and the Minnesota multistate cooperative (MMCAP) serving Minnesota and Oregon participants. Recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 with a small local business enterprise set-aside and 5 percent bid discount; MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers with contract effectiveness July 1, 2026; and the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) for information on direct-to-manufacturer prescription program capabilities. The mismatch between the stated UNSPSC commodity name and the actual work being purchased suggests a tagging error or data integrity issue at the source.